Risk of Ischemic Stroke Associated with Antidepressant Drug Use in Elderly Persons

Journal of Clinical Psychopharmacology

Volumn 30, Issue 3, 2010, Pages 252-258

  Trifirò, Gianluca ^a,b,c   Dieleman, Jeanne ^a   Sen, Elif F ^a   Gambassi, Giovanni ^d   Sturkenboom, Miriam C J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MESSINA   (Italy)

^c IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

Author keywords

Antidepressant drug; Cerebral ischemia; Stroke

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOSULEPIN; DOXEPIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; LOFEPRAMINE; MAPROTILINE; MIANSERIN; MIRTAZAPINE; NEFAZODONE; NORTRIPTYLINE; OPIPRAMOL; PAROXETINE; REBOXETINE; SERTRALINE; TRAZODONE; TRIMIPRAMINE; VENLAFAXINE;

AGED; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DEPRESSION; DRUG SAFETY; DRUG USE; ELDERLY CARE; FEMALE; HIGH RISK POPULATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; TREATMENT DURATION;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; STROKE;

EID: 77952373634     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181dca10a     Document Type: Article

References (30)

1. Unutzer J. Diagnosis and treatment of older adults with depression in primary care. Biol Psychiatry. 2002;52:285-292.
2. Isacsson G, Boethius G, Henriksson S. Selective serotonin reuptake inhibitors have broadened the utilisation of antidepressant treatment in accordance with recommendations. Findings from a Swedish prescription database. J Affect Disord. 1999;53:15-22.
3. Draper B, Berman K. Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly. Drugs Aging. 2008;25:501-519.
4. Skop BP, Brown TM. Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors. Psychosomatics. 1996;37:12-16.
5. Ottervanger JP, Stricker BJCH, Huls J, et al. Bleeding attributed to the intake of paroxetine. Am J Psychiatry. 1994;151:781-782.
6. Layton D, Clark DW, Pearce GL, et al. Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England. Eur J Clin Pharmacol. 2001;57:167-176.
7. Ramasubbu R. Cerebrovascular effects of selective serotonin reuptake inhibitors: a systematic review. J Clin Psychiatry. 2004;65:1642-1653.
8. Sauer WH, Berlin JA, Kimmel SE. Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation. 2003;108:32-36.
9. Monster TB, Johnsen SP, Olsen ML, et al. Antidepressants and risk of first-time hospitalization for myocardial infarction: a population-based case-control study. Am J Med. 2004;1117:732-737.
10. Singhal AB, Caviness VS, Begleiter AF, et al. Cerebral vasoconstriction and stroke after use of serotonergic drugs. Neurology. 2002;58:130-133.
11. Molaie M. Serotonin syndrome presenting with migrainelike stroke. Headache. 1997;37:519-521.
12. De Abajo FJ, Jick H, Derby L, et al. Intracranial haemorrhage and use of selective serotonin reuptake inhibitors. Br J Clin Pharmacol. 2000;50: 43-47.
13. Barbui C, Andretta M, De Vitis G, et al. Antidepressant drug prescription and risk of abnormal bleeding: a case-control study. J Clin Psychopharmacol. 2009;29:33-38.
14. Kharofa J, Sekar P, Haverbusch M, et al. Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Stroke. 2007;38:3049-3051.
15. Elkind MS. Stroke in the elderly. Mt Sinai J Med. 2003;70:27-37.
16. Barbui C, Percudani M, Fortino I, et al. Past use of selective serotonin reuptake inhibitors and the risk of cerebrovascular events in the elderly. Int Clin Psychopharmacol. 2005;20:169-171.
17. Chen Y, Guo JJ, Li H, et al. Risk of cerebrovascular events associated with antidepressant use in patients with depression: a population-based, nested case-control study. Ann Pharmacother. 2008;42:177-184.
18. Bak S, Tsiropoulos I, Kjaersgaard JO, et al. Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study. Stroke. 2002;33:1465-1473.
19. van der Lei J, Duisterhout JS, Westerhof HP, et al. The introduction of computer-based patient records in The Netherlands. Ann Intern Med. 1993;119:1036-1041.
20. Lamberts H, Wood M, Hofmans-Okkes IM. International primary care classifications: the effect of fifteen years of evolution. Fam Pract. 1992;9:330-339.
21. Vlug AE, van der Lei J, Mosseveld BM, et al. Post-marketing surveillance based on electronic patient records: the IPCI project. Methods Inf Med. 1999;38:339-344.
22. Krishnan KRR. Depression as a contributing factor in cerebrovascular disease. Am Heart J. 2000;140:S70YS76.
23. Beaumont JJ, Steenland K, Minton A, et al. A computer program for incidence density sampling of controls in case-control studies nested within occupational cohort studies. Am J Epidemiol. 1989;129: 212-219.
24. World Health Organization. ATC/DDD Index 2010. Available at: http://www.whocc.no/atcddd/indexdatabase/. Accessed February 1, 2009.
25. Everson SA, Roberts RE, Goldberg DE, et al. Depressive symptoms and increased risk of stroke mortality over a 29-year period. Arch Intern Med. 1998;158:1133-1138.
26. Salaycik KJ, Kelly-Hayes M, Beiser A, et al. Depressive symptoms and risk of stroke: the Framingham Study. Stroke. 2007;38:16-21.
27. Bonvento G, MacKenzie ET, Edvinsson L. Serotonergic innervation of the cerebral vasculature: relevance to migraine and ischaemia. Brain Res Brain Res Rev. 1991;16:257-263.
28. Muhonen MG, Robertson SC, Gerdes JS, et al. Effects of serotonin on cerebral circulation after middle cerebral artery occlusion. J Neurosurg. 1997;87:301-306.
29. Tatsumi M, Groshan K, Blakely RD, et al. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 1997;340:249-258.
30. Maidment R, Livingston G, Katona C. Just keep taking the tablets: adherence to antidepressant treatment in older people in primary care. Int J Geriatr Psychiatry. 2002;17:752-757.